RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-12-11
DOI
10.1093/carcin/bgz141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells
- (2017) Ju-Ha Kim et al. PLoS One
- Insulin, insulin receptors, and cancer
- (2016) R. Vigneri et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Highly specific role of the insulin receptor in breast cancer progression
- (2015) R. Rostoker et al. ENDOCRINE-RELATED CANCER
- CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B
- (2015) Liang Xia et al. International Journal of Biological Sciences
- The prognostic value of phosphorylated Akt in breast cancer: a systematic review
- (2015) Zu-Yao Yang et al. Scientific Reports
- CUG-binding protein 1 (CUGBP1) expression and prognosis of brain metastases from non-small cell lung cancer
- (2015) Xiaofei Wang et al. Thoracic Cancer
- Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells
- (2013) Sudha Talwar et al. RNA Biology
- The role of CUGBP1 in age-dependent changes of liver functions
- (2012) Karlie Jones et al. AGEING RESEARCH REVIEWS
- Quantifying insulin receptor isoform expression in FFPE breast tumors
- (2012) Sean C. Harrington et al. GROWTH HORMONE & IGF RESEARCH
- Targeting Insulin and Insulin-Like Growth Factor Signaling in Breast Cancer
- (2012) Yuzhe Yang et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Insulin-like Growth Factor Receptor Inhibitors: Baby or the Bathwater?
- (2012) D. Yee JNCI-Journal of the National Cancer Institute
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The IGF Pathway Regulates ERα through a S6K1-Dependent Mechanism in Breast Cancer Cells
- (2011) Marc A. Becker et al. MOLECULAR ENDOCRINOLOGY
- Altered Expression of Insulin Receptor Isoforms in Breast Cancer
- (2011) Jiaqi Huang et al. PLoS One
- The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins
- (2011) Twishasri Dasgupta et al. Wiley Interdisciplinary Reviews-RNA
- HER2 Silences Tumor Suppression in Breast Cancer Cells by Switching Expression of C/EBP Isoforms
- (2010) A. Arnal-Estape et al. CANCER RESEARCH
- Muscleblind-like 1 (Mbnl1) Promotes Insulin Receptor Exon 11 Inclusion via Binding to a Downstream Evolutionarily Conserved Intronic Enhancer
- (2010) Supriya Sen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Insulin-Like Growth Factor Type 1 Receptor and Insulin Receptor Isoform Expression and Signaling in Mammary Epithelial Cells
- (2009) Anne M. Rowzee et al. ENDOCRINOLOGY
- CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases
- (2009) Cynthia A. Zahnow EXPERT REVIEWS IN MOLECULAR MEDICINE
- Crosstalk Between IGF1R and Estrogen Receptor Signaling in Breast Cancer
- (2008) Dedra H. Fagan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- SRp20 and CUG-BP1 Modulate Insulin Receptor Exon 11 Alternative Splicing
- (2008) S. Sen et al. MOLECULAR AND CELLULAR BIOLOGY
- Conserved GU-Rich Elements Mediate mRNA Decay by Binding to CUG-Binding Protein 1
- (2008) Irina A. Vlasova et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started